Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis

Liver International

Volumn 29, Issue 6, 2009, Pages 797-809

  Berg, Christoph P ^a   Kannan, Thirumalai R ^b   Klein, Reinhild ^a   Gregor, Michael ^a   Baseman, Joel B ^b   Wesselborg, Sebastian ^a   Lauber, Kirsten ^a   Stein, Gerburg M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aetiopathogenesis; Autoimmune diseases; Molecular mimicry; Mycoplasma pneumoniae; Pyruvate dehydrogenase complex

Indexed keywords

AZATHIOPRINE; BACTERIAL ANTIGEN; CARDS TX ANTIGEN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MITOCHONDRION ANTIBODY; PYRUVATE DEHYDROGENASE BETA ANTIGEN; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE COMPLEX E1 BETA ANTIGEN; PYRUVATE DEHYDROGENASE COMPLEX E2; PYRUVATE DEHYDROGENASE COMPLEX E2 ANTIGEN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; CROSS REACTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOLECULAR MIMICRY; MYCOPLASMA PNEUMONIAE; MYCOPLASMOSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; ANTIBODIES; BLOTTING, WESTERN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GERMANY; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MOLECULAR MIMICRY; MYCOPLASMA; PYRUVATE DEHYDROGENASE COMPLEX; SELF TOLERANCE; SUS SCROFA;

EID: 67049119858     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01942.x     Document Type: Article

References (39)

1. Christen U, Von Herrath MG. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol 2004; 40: 1113-20.
2. Cole BC, Griffiths MM. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arthritis Rheum 1993; 36: 994-1002.
3. Jansson E, Backman A, Hakkarainen K, Miettinen A, Seniusova B. Mycoplasmas and arthritis. Z Rheumatol 1983; 42: 315-9.
4. Ramirez AS, Rosas A, Hernandez-Beriain JA, et al. Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: A case-control study. Rheumatology 2005; 44: 912-4.
5. Sack J, Zilberstein D, Barile MF, et al. Binding of thyrotropin to selected Mycoplasma species: Detection of serum antibodies against a specific Mycoplasma membrane antigen in patients with autoimmune thyroid disease. J Endocrinol Invest 1989; 12: 77-86.
6. Mackay IR, Whittingham S, Fida S, et al. The peculiar autoimmunity of primary biliary cirrhosis. Immunol Rev 2000; 174: 226-37.
7. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-73.
8. Gershwin ME, Rowley M, Davis PA, et al. Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies. Prog Liver Dis 1992; 10: 47-61.
9. Leung PS, Coppel RL, Gershwin ME. Etiology of primary biliary cirrhosis: the search for the culprit. Semin Liver Dis 2005; 25: 327-36.
10. Mackay IR. The etiopathogenesis of autoimmunity. Semin Liver Dis 2005; 25: 239-50.
11. Dallo SF, Kannan TR, Blaylock MW, Baseman JB. Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol 2002; 46: 1041-51.
12. Layh-Schmitt G, Podtelejnikov A, Mann M. Proteins complexed to the P1 adhesin of Mycoplasma pneumoniae. Microbiology 2000; 146(Part 3): 741-7.
13. Berg CP, Stein GM, Klein R, et al. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients. Liver Int 2006; 26: 846-55.
14. Kaplan MM. Novosphingobium aromaticivorans: A potential initiator of primary biliary cirrhosis. Am J Gastroenterol 2004; 99: 2147-9.
15. Jan G, Le Henaff M, Fontenelle C, Wroblewski H. Biochemical and antigenic characterisation of Mycoplasma gallisepticum membrane proteins P52 and P67 (pMGA). Arch Microbiol 2001; 177: 81-90.
16. Wallbrandt P, Tegman V, Jonsson BH, Wieslander A. Identification and analysis of the genes coding for the putative pyruvate dehydrogenase enzyme complex in Acholeplasma laidlawii. J Bacteriol 1992; 174: 1388-96.
17. Manns MP, Bremm A, Schneider PM, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991; 101: 1367-73.
18. Selmi C, Invernizzi P, Zuin M, et al. Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun 2005; 6: 543-56.
19. Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci USA 2006; 103: 6724-9.
20. Himmelreich R, Hilbert H, Plagens H, et al. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res 1996; 24: 4420-49.
21. Klein R, Pointner H, Zilly W, et al. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: A prospective study on 200 patients followed for 10 years. Liver 1997; 17: 119-28.
22. Klein R, Huizenga JR, Gips CH, Berg PA. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation. J Hepatol 1994; 20: 181-9.
23. Engels IH, Stepczynska A, Stroh C, et al. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 2000; 19: 4563-73.
24. Jensen JS, Sondergard-Andersen J, Uldum SA, Lind K. Detection of Mycoplasma pneumoniae in simulated clinical samples by polymerase chain reaction. Brief report. Apmis 1989; 97: 1046-8.
25. Johnson S, Sidebottom D, Bruckner F, Collins D. Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease. J Clin Microbiol 2000; 38: 90-3.
26. Friedman SM, Crow MK, Tumang JR, et al. Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): Generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells. J Exp Med 1991; 174: 891-900.
27. Burroughs AK, Rosenstein IJ, Epstein O, et al. Bacteriuria and primary biliary cirrhosis. Gut 1984; 25: 133-7.
28. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 2001; 33: 16-21.
29. Arav-Boger R, Assia A, Spirer Z, Bujanover Y, Reif S. Cholestatic hepatitis as a main manifestation of Mycoplasma pneumoniae infection. J Pediatr Gastroenterol Nutr 1995; 21: 459-60.
30. Suzuyama Y, Iwasaki H, Izumikawa K, Hara K. Clinical complications of Mycoplasma pneumoniae disease - other organs. Yale J Biol Med 1983; 56: 487-91.
31. Daxboeck F, Gattringer R, Mustafa S, Bauer C, Assadian O. Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia. Clin Microbiol Infect 2005; 11: 507-10.
32. Kikuchi K, Lian ZX, Kimura Y, et al. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 2005; 24: 347-52.
33. Selmi C, Balkwill DL, Invernizzi P, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003; 38: 1250-7.
34. Zeniya M. Lessons from animal models of primary biliary cirrhosis. J Gastroenterol Hepatol 2000; 15: 342-3.
35. Johnson L, Wirostko E, Wirostko W. Primary biliary cirrhosis in the mouse: Induction by human mycoplasma-like organisms. Int J Exp Pathol 1990; 71: 701-12.
36. Irie J, Wu Y, Wicker LS, et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006; 203: 1209-19.
37. Wakabayashi K, Lian ZX, Moritoki Y, et al. IL-2 receptor alpha (-/-) mice and the development of primary biliary cirrhosis hepatology, 2006; 44: 1240-9.
38. Oertelt S, Lian ZX, Cheng CM, et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006; 177: 1655-60.
39. Thompson JD, Higgins DG, Gibson TJ, Clustal W. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673-80.